Dianthus Therapeutics Inc...

NASDAQ: DNTH · Real-Time Price · USD
20.71
0.46 (2.27%)
At close: Aug 15, 2025, 3:59 PM
20.74
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Dianthus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
6.24M 2.83M 6.42M 1.48M
Cost of Revenue
n/a 355K 147K 2.02M
Gross Profit
6.24M 2.83M 6.27M -544K
Operating Income
-101.86M -48.17M -29.7M -74.69M
Interest Income
17.36M 4.76M 1.15M 100K
Pretax Income
-84.97M -43.55M -28.48M -13.11M
Net Income
-84.97M -43.55M -28.48M -13.11M
Selling & General & Admin
24.99M 18.16M 6.74M 1.96M
Research & Development
83.11M 32.84M 29.38M 12.61M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
108.1M 51M 36.12M 14.56M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
108.1M 51M 36.12M 14.56M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
33.31M 5.15M 3.75M 3.43M
Shares Outstanding (Diluted)
33.31M 5.15M 3.75M 3.43M
EPS (Basic)
-2.55 -8.45 -7.6 -3.82
EPS (Diluted)
-2.55 -8.45 -7.6 -3.82
EBITDA
-101.45M -47.82M -29.56M -69.12M
EBIT
-101.86M -48.17M -29.7M -71.14M
Depreciation & Amortization
412K 355K 147K 2.02M